Sanofi latest IG borrower to reprice loan

By Michael Turner
13 Jan 2014

French pharmaceutical company Sanofi, rated A1/AA, has amended a €7bn credit line, stretching the tenor out by a year and cutting the pricing.

The loan, signed in 2011, was due to mature in 2017, but will now be repaid a year later. The new deal also has two one year extension options. 

"This facility has neither rating grid nor financial covenants," said a Sanofi spokesperson by email. 

The spokesperson added: "In addition to ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.